Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2014-01-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Dietary Fat When Eaten With Fructose Versus Glucose
NCT01061346
The Metabolic Effects of a High Fructose Versus a High Glucose Diet in Overweight Men
NCT01050140
A Comparison of the Metabolic Effects of Fructose, Glucose, High Fructose Corn Syrup and Sucrose at Normal Population Consumed Levels in Adults Aged 20-60 Years Old
NCT01797042
Dietary Fructose on Microbiota and Hepatosteatosis
NCT04898621
The Impact of Sucrose Ingestion Post-Exercise on Liver and Muscle Glycogen Repletion.
NCT02344381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
POPULATION 10 healthy males aged between 20 and 40 years, with a BMI between 20-25kg/m2, with normal liver fat levels (\<5%) and fasting plasma glucose and no evidence of insulin resistance will be recruited. No pre-existing morbidity including cardiac, hepatic or renal disease, history of diabetes, hypertension or hyperlipidemia. Usual physical activity of subjects to range from sedentary to a maximum of meeting the UK minimum activity recommendations (30 min moderate exercise 5 d/week). Habitual alcohol intake of less than 2 units per day.
TREATMENT Pre-intervention: Participants will be asked to record habitual dietary intake by completion of a 7-day food diary and be asked to wear an accelerometer armband to assess physical activity before each intervention week. Resting energy expenditure will also be assessed by indirect calorimetry.
7 day dietary interventions: Participants will be resident at the clinical research facility at Hammersmith Hospital during each intervention week for 5 out of the 7 days and all food will be provided at the facility. At the weekends, participants will have to leave the unit but food will be provided for those two days so that the diet can be continued at home.
At the start and end of each 7 day intervention: Weight, height and waist circumference will be taken; percentage liver fat and total and regional body composition will be measured by MRI. Fasting and post prandial plasma glucose, insulin and lipids will be measured and blood pressure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High sucrose diet
High sucrose diet for 7 days
Sucrose
Low sucrose diet
Low sucrose diet for 7 days
Sucrose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sucrose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Gained or lost ≥ 3kg weight in the past three months
* Use of medication likely to interfere with metabolism, appetite regulation, glucose homeostasis and hormonal balance
* Regular consumer of sugar sweetened beverages
* Any chronic illness
* Cardiovascular, hepatic or renal disease
* Excess alcohol intake (\>2 units per day)
* Exceeding UK minimum activity recommendation (30min moderate exercise 5d/wk)
* Current smokers (smoked within last 6 months)
* Any gastrointestinal disorder e.g. Crohn's disease, coeliac disease or irritable bowel syndrome
* A history of drug or alcohol abuse in the last 2 years
* Pancreatitis
* Unable to have MRI (eg. metallic or magnetic implants, claustrophobia)
20 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary Frost
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NIHR/Wellcome Trust Imperial Clinical Research Facility
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SucroseLiver
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.